Faculty profile

Anna Lam

ResearcherMedicineUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.

Anna Lam

Researcher

Medicine

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
15 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cell Therapy Islet Transplant Patient Perspective Qualitative Interviews Type 1 Diabetes

Latest papers

Relationship between participant-reported outcomes, residual beta cell function and metabolic parameters in youth with newly diagnosed type 1 diabetes.
Diabetologia · 2026
Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy: A Prospective Observational Study.
Annals of surgery · 2025
High-dose Hook Effect in a Case of Giant Prolactinoma Confounded by Acute Kidney Injury.
JCEM case reports · 2025 · first author

All 23 publications

Latest funding

Freedom and Flexibility - Communicating the Experiences of Beta Cell Replacement to Patients and Providers
CIHR · 2024 · Principal investigator
$62,177
A First-in-human Trial of Autologous Induced Pluripotent Stem Cells (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
CIHR · 2021 · Co-investigator
$1,000,000
A First-in-human Trial of Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
CIHR · 2020 · Co-investigator
$10,000

All 3 grants and awards

23 publications.

Relationship between participant-reported outcomes, residual beta cell function and metabolic parameters in youth with newly diagnosed type 1 diabetes.

Taylor PN, Cheung WY, Lagorio Price J, Boughton C, Bowen-Morris J, Hutchings HA, Hanna SJ, Luzio S, Tatovic D, Marwaha A, Fuchs J, Lam A, Gregory JW, Hovorka R, Dayan CM

Diabetologia2026

DOI: 10.1007/s00125-026-06798-z PMID: 42467087

Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy: A Prospective Observational Study.

Czarnecka Z, Verhoeff K, Carr ALJ, Lam A, Senior P, Lucciantonio R, Kin T, Pepper AR, Bigam DL, Dajani K, Anderson B, Shapiro AMJ

Annals of surgery2025

DOI: 10.1097/sla.0000000000006909 PMID: 40793922

High-dose Hook Effect in a Case of Giant Prolactinoma Confounded by Acute Kidney Injury.

Lam A, Prosser C, Chik CL

JCEM case reports2025First author

DOI: 10.1210/jcemcr/luaf136 PMID: 40584813

Sequential islet transplants for type 1 diabetes are not associated with sustained or cumulative increases in hepatic portal venous pressure.

Carr ALJ, Shah R, Marfil-Garza BA, Lam A, Dajani K, Anderson B, Owen RTJ, O'Gorman D, Kin T, Bigam D, Shapiro AMJ, Senior PA

PloS one2025

DOI: 10.1371/journal.pone.0329074 PMID: 40729316

Evaluating Islet Cell Isolation and Transplantation From Donors Following Medical Assistance in Dying.

Parente A, Verhoeff K, Kin T, Hefler J, Marfil-Garza BA, Sanchez-Fernandez N, Lam A, Lyon J, O'Gorman D, Dajani KZ, Anderson BL, Bigam DL, MacDonald PE, Shapiro AMJ

Transplantation direct2024

DOI: 10.1097/txd.0000000000001667 PMID: 38911274

Islet transplantation outcomes in type 1 diabetes and transplantation of HLA-DQ8/DR4: results of a single-centre retrospective cohort in Canada.

Forbes S, Halpin A, Lam A, Grynoch D, Parker R, Hidalgo L, Bigam D, Anderson B, Dajani K, Kin T, O'Gorman D, Senior PA, Campbell P, Shapiro AMJ

EClinicalMedicine2024

DOI: 10.1016/j.eclinm.2023.102333 PMID: 38169703

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.

Taylor PN, Collins KS, Lam A, Karpen SR, Greeno B, Walker F, Lozano A, Atabakhsh E, Ahmed ST, Marinac M, Latres E, Senior PA, Rigby M, Gottlieb PA, Dayan CM, Trial Outcome Markers Initiative collaboration

The lancet. Diabetes & endocrinology2023

DOI: 10.1016/s2213-8587(23)00267-x PMID: 37931637

C-peptide Targets and Patient-centered Outcomes of Relevance to Cellular Transplantation for Diabetes.

Verhoeff K, Marfil-Garza BA, Dajani K, Bigam DL, Anderson B, Kin T, Lam A, O'Gorman D, Senior PA, Shapiro AMJ

Transplantation2023

DOI: 10.1097/tp.0000000000004328 PMID: 36253897

Acetylsalicylic Acid (Aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Liu S, Eckstein J, Lam A, Cheema AN

Current vascular pharmacology2023

DOI: 10.2174/1570161121666230131120544 PMID: 36718966

Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.

Morrison AE, Senior PA, Bubela T, Farnsworth K, Witteman HO, Lam A

Canadian journal of diabetes2022Senior author

DOI: 10.1016/j.jcjd.2022.06.003 PMID: 35945126

Something wrong or missing on this profile? Suggest a correction

Anna Lam

Research

Latest papers

Latest funding

Relationship between participant-reported outcomes, residual beta cell function and metabolic parameters in youth with newly diagnosed type 1 diabetes.

Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy: A Prospective Observational Study.

High-dose Hook Effect in a Case of Giant Prolactinoma Confounded by Acute Kidney Injury.

Sequential islet transplants for type 1 diabetes are not associated with sustained or cumulative increases in hepatic portal venous pressure.

Evaluating Islet Cell Isolation and Transplantation From Donors Following Medical Assistance in Dying.

Islet transplantation outcomes in type 1 diabetes and transplantation of HLA-DQ8/DR4: results of a single-centre retrospective cohort in Canada.

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.

C-peptide Targets and Patient-centered Outcomes of Relevance to Cellular Transplantation for Diabetes.

Acetylsalicylic Acid (Aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.

Freedom and Flexibility - Communicating the Experiences of Beta Cell Replacement to Patients and Providers

A First-in-human Trial of Autologous Induced Pluripotent Stem Cells (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy

A First-in-human Trial of Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy

Frequent collaborators

Kate Farnsworth

Peter Senior

Anne Halpin

Rémi Rabasa-Lhoret

Rémi Rabasa-Lhoret

Bruce Perkins

Peter Senior

Ashish Marwaha